• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

FDA

FDA clears Philips’ Smart CT application software

April 6, 2021 By Sean Whooley Leave a Comment

Royal Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its Philips SmartCT application software. Amsterdam-based Philips’ SmartCT software is a component of the company’s Azurion image-guided therapy system for diagnosis, therapy planning, treatment and follow-up for interventional radiology procedures. SmartCT helps to enhance clinical confidence, smooth the workflow and increase productivity through […]

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Health Technology, Imaging, Regulatory/Compliance, Surgical Tagged With: FDA, Philips

Medtronic can’t shake suit over FDA clearance of spinal devices

April 6, 2021 By Nancy Crotti Leave a Comment

A federal appeals court has ruled that Medtronic must face a whistleblower lawsuit over FDA clearance of certain spinal fusion devices. The Dan Abrams Company sued Medtronic in 2015 claiming that Medtronic defrauded the FDA into granting 510(k) clearance to certain Verte-Stack cervical vertebral body replacement (VBR) devices used in spinal fusion surgeries. The lawsuit […]

Filed Under: 510(k), Food & Drug Administration (FDA), Legal News, Regulatory/Compliance, Spine Tagged With: FDA, Medtronic

MTF Biologics says FDA used old data to malign its surgical mesh

April 6, 2021 By Nancy Crotti Leave a Comment

A surgical mesh company claims the FDA improperly called one of its products’ safety into question. The agency said last week that two surgical mesh brands used off-label in breast reconstruction surgery have had “significantly higher major complication rates.” It named FlexHD by MTF Biologics and AlloMax by BD as having had higher rates of explantation, reoperations and infections two years […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Regulatory/Compliance, Surgical, Women's Health Tagged With: FDA, MTF Biologics

Feds put J&J in charge of vaccine production at Emergent plant

April 5, 2021 By Sean Whooley Leave a Comment

Johnson & Johnson (NYSE:JNJ) announced that it assumed full responsibility for the production of its COVID-19 vaccine at the Emergent BioSolutions Bayview (Baltimore) facility. The company’s announcement comes days after news broke that a factory error made at that facility resulted in 15 million discarded COVID-19 vaccines. Get the full story at our sister site, […]

Filed Under: Contract Manufacturing, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Emergent BioSolutions, FDA, Johnson & Johnson

FDA clears Orthofix 3D-printed titanium cervical spacer system

April 5, 2021 By Sean Whooley Leave a Comment

Orthofix Medical (NSDQ:OFIX) announced today that it received FDA 510(k) clearance for its Construx Mini Ti spacer system. Lewisville, Texas–based Orthofix also administered the first patient implant of the 3D-printed Construx Mini Ti system, which is designed to enhance anterior cervical discectomy and fusion (ACDF) procedures, according to a news release. The Construx Mini Ti […]

Filed Under: 510(k), Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Orthopedics, Regulatory/Compliance, Spine Tagged With: 3D printing, FDA, Orthofix

FDA flags infection risk from reusable urological endoscopes

April 1, 2021 By Nancy Crotti Leave a Comment

The FDA said today that is looking into the causes of infections from reprocessed urological endoscopes based on “numerous” adverse event reports. The agency said that since 2017 it has received more than 450 medical device reports — including three deaths — associated with reprocessed cystoscopes, ureteroscopes and cystourethroscopes used for viewing and accessing the […]

Filed Under: Endoscopic, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, Karl Storz, Olympus

FDA authorizes use of over-the-counter COVID-19 tests for screening

April 1, 2021 By Sean Whooley Leave a Comment

The FDA announced today that it authorized several COVID-19 tests for over-the-counter use in asymptomatic screening. Among the tests authorized were the BinaxNow Ag card from Abbott (which includes point-of-care screening) and the Quidel Quick-View at-home test. FDA also authorized the BD Veritor Plus system for POC screening with a prescription. “BD is supporting the […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, BD, becton dickinson, coronavirus, COVID-19, FDA, Quidel

FDA warns on use of certain surgical mesh in breast reconstruction

April 1, 2021 By Nancy Crotti Leave a Comment

Two surgical mesh brands used off-label in breast reconstruction surgery have had “significantly higher major complication rates,” according to an FDA analysis. Patients implanted with  FlexHD by MTF Biologics and AlloMax by BD had higher rates of explantation, reoperations and infections two years after surgery when compared with patients who received one of two other […]

Filed Under: Featured, Food & Drug Administration (FDA), Implants, Regulatory/Compliance, Women's Health Tagged With: BD, FDA, MTF Biologics

Abbott’s rapid COVID-19 self-test is now over-the-counter

April 1, 2021 By Sean Whooley Leave a Comment

Abbott (NYSE:ABT) announced that it received FDA emergency use authorization (EUA) for over-the-counter use of its BinaxNOW COVID-19 test. The new indication for the diagnostic allows individuals with or without symptoms to access the BinaxNOW COVID-19 Ag self-test over the counter, without a prescription. The company plans to begin shipping to major food, drug and […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Genomics/Molecular Diagnostics, Regulatory/Compliance Tagged With: Abbott, coronavirus, COVID-19, FDA

FDA approves inhaled pulmonary hypertension treatment from United Therapeutics

April 1, 2021 By Sean Whooley Leave a Comment

United Therapeutics (NSDQ:UTHR) announced today that it received FDA approval for its Tyvaso inhalation solution for pulmonary hypertension. Research Triangle Park, N.C.–based United Therapeutics’ Tyvaso (treprostinil) inhalation solution is designed to treat patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) to improve exercise ability, according to a news release. Get the full story […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Respiratory Tagged With: FDA, United Therapeutics

BlueStar Genomics gains breakthrough nod for pancreatic cancer test

March 31, 2021 By Sean Whooley Leave a Comment

Bluestar Genomics announced today that it received FDA breakthrough device designation for its pancreatic cancer test. San Diego-based Bluestar’s proprietary noninvasive pancreatic cancer detection test is designed for use with patients with new-onset diabetes, according to a news release. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Clinical Trials, Diabetes, Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Bluestar Genomics, FDA

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 90
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS